|
FOR IMMEDIATE RELEASE June 5, 2008 Local Pharmacist Lobbies Congress to Protect Access to Bioidentical Hormones Hickory, NC Compounding pharmacists from across the nation stormed Capitol Hill this month to lobby members of Congress to protect access to commonly compounded bioidentical hormones. Bill & Jan Mixon of The Compounding Pharmacy in Hickory made the trip to Washington, D.C. While meeting with various elected officials and their staff, The Mixons and their colleagues discussed the value of pharmacy compounding and bioidentical hormone replacement therapy (BHRT). Earlier this year, the Food and Drug Administration (FDA) asserted a new policy to deny women access to bioidentical hormones.
 Wyeth Pharmaceuticals, the number one manufacturer of synthetic hormone products, petitioned the FDA to restrict the compounding of medications containing estriol, an estrogen produced by the human body. Like many commonly prescribed drugs, estriol has a monograph from the U.S. Pharmacopeia (USP), but is not a component of an FDA-approved drug. When it passed the FDA Modernization Act in 1997, Congress clearly indicated that drugs with a USP monograph could be compounded. "This trip gave us a chance to have our voices heard by members of Congress," said Mixon. "With help from thousands of patients and prescribers who called and wrote their members of Congress, our voices were heard loud and clear on Capitol Hill." The trip to Washington, D.C., dubbed Compounders on Capitol Hill, was the 14th annual trip coordinated by the International Academy of Compounding Pharmacists (IACP). It was the Mixon's 9th time joining the group. The Mixon's visit to Congress came at a particularly critical time for their business, and similar compounding pharmacies across the country. Last month several key representatives introduced H. Con. Res. 342. The bipartisan resolution states that "the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest and called on the FDA to reverse its policy." Pharmacists were greeted with an overwhelming sense of support from their members of Congress regarding H. Con. Res. 342. "This is an important step for compounding pharmacies like ours. We fill an important void for hundreds of thousands of women whose needs can't be met by manufactured medicines. They rely on us and we simply don't know where they would get the medicines they need if we couldn't compound with bioidentical hormones anymore" said, Jan Mixon, RN at The Compounding Pharmacy. Pharmacy compounding is a long-standing pharmacy practice that enables doctors to prescribe customized pharmaceutical treatments for patients when one-size-fits-all manufactured products are inappropriate. While pharmacy compounding is regulated by state boards of pharmacy, pharmaceutical manufacturers are pushing for onerous, federal restrictions that would restrict patients access to needed medications. The Compounding Pharmacy opened its doors November 1998 to serve the need for pharmacy compounding. In 2007 the pharmacy was recognized by the Pharmacy Compounding Accreditation Board as one of 42 pharmacies nationwide which adhere to strict practice standards. The Mixons were awarded the 2008 Faith in the Future Award by the Catawba County Chamber of Commerce for their business category. The Mixons live in Hickory and have 2 daughters. Bill Mixon, RPh, MS, FIACP and Jan Mixon, BSN, RN are the owners of The Compounding Pharmacy. It has been in business since 1998 and is located at 750 4th St SW Hickory, NC. It specializes in compounding unique, one of a kind medications for human and veterinary use.
|